Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …
MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …
2018 ESC/EACTS Guidelines on myocardial revascularization
M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association …
Writing Committee Members, SS Virani… - Journal of the American …, 2023 - jacc.org
Abstract Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …
of Patients With Chronic Coronary Disease” provides an update to and consolidates new …
[HTML][HTML] Timing of complete revascularization with multivessel PCI for myocardial infarction
BE Stähli, F Varbella, A Linke, B Schwarz… - … England Journal of …, 2023 - Mass Medical Soc
Background In patients with ST-segment elevation myocardial infarction (STEMI) with
multivessel coronary artery disease, the time at which complete revascularization of …
multivessel coronary artery disease, the time at which complete revascularization of …
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary …
H Watanabe, T Morimoto, M Natsuaki… - JAMA …, 2022 - jamanetwork.com
Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with …
percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with …
2018 ESC/EACTS Guidelines on myocardial revascularization
FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
websites. The National Societies of the ESC are encouraged to endorse, translate, and …
Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving …
H Watanabe, T Domei, T Morimoto, M Natsuaki… - Jama, 2019 - jamanetwork.com
Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual …
Background Numerous randomised trials have compared coronary artery bypass grafting
(CABG) with percutaneous coronary intervention (PCI) for patients with coronary artery …
(CABG) with percutaneous coronary intervention (PCI) for patients with coronary artery …
Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex …
K Takahashi, PW Serruys, V Fuster, ME Farkouh… - The Lancet, 2020 - thelancet.com
Background Randomised controlled trials are considered the gold standard for testing the
efficacy of novel therapeutic interventions, and typically report the average treatment effect …
efficacy of novel therapeutic interventions, and typically report the average treatment effect …